"The Story of Everything" documentary argues scientific discoveries about the universe, DNA and fine-tuning point to the ...

Elliot Page speaks to PEOPLE about queer representation, childhood shame and his new documentary, 'Second Nature,' which ...

Author Lee Strobel admitted he’s “jealous” of religious skeptics in new documentary THE STORY OF EVERYTHING.  “Let’s face it, ...

OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...

Lee Strobel shares how the new documentary The Story of Everything presents a science-driven case for the existence of God, ...

A major biotech company is leaving the Bay Area. Pfizer is abandoning its research site at 181 Oyster Point Blvd. in South San Francisco. The biotech company will move out of the building by the end ...

CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year. Growing sales of Casgevy plus new candidates ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

Biotech has benefited marginally from this rotation. Value beat growth notably in the first quarter. The energy sector was obviously the best performing of the 11 sectors of the S&P 500 in Q1 with a ...

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2025, biotechnology stocks had their best year since the COVID-19 ...